We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App

Celiac Disease Blood Test to Eliminate Painful Biopsies

By LabMedica International staff writers
Posted on 21 Sep 2023
Print article
Image: Biopsy-free diagnosis of celiac disease in adults has shown promising results (Photo courtesy of Freepik)
Image: Biopsy-free diagnosis of celiac disease in adults has shown promising results (Photo courtesy of Freepik)

There is still a controversy over whether it is possible to diagnose celiac disease in adults using only serology. Now, a study has found that a simple test for measuring the levels of anti-tissue transglutaminase IgA (tTG-IgA) in the blood could be used as a diagnostic threshold in predicting duodenal villous atrophy, a key feature of celiac disease.

Researchers from the University of Salerno (Fisciano SA, Italy) conducted a study on a cohort of individuals suspected to have celiac disease. After certain exclusions, the final cohort included 436 individuals, comprising 296 women and 140 men, with an average age of 40. These participants hailed from various global regions, mostly Europe, followed by Asia, Oceania, and South America.

Based on their symptoms, the participants were divided into three categories: those showing classical symptoms like anemia, weight loss, or diarrhea; those with atypical symptoms; and those who were suspected to have celiac disease based on family history or other associated autoimmune conditions. Duodenal tissue samples were collected from the participants via endoscopy and were assessed by local pathologists at 14 different sites. Additionally, tTG-IgA levels were measured in both local and central labs. A result was considered positive if tTG-IgA levels exceeded one time the upper limit of normal (ULN).

Out of the cohort, 363 participants (or 83%) had tTG-IgA levels above the threshold, while 73 (or 17%) had levels below it. Among those with elevated tTG-IgA, 341 were confirmed to have celiac disease through histological review, whereas 22 did not have the disease. Of the participants with low tTG-IgA, seven were false negatives with positive histology, and 66 were true negatives. Importantly, the study found that tTG-IgA concentrations that were 5, 10, or 15 times higher than the ULN offered the most reliable diagnostic accuracy, suggesting that 10 times the ULN could be a useful diagnostic threshold. This study validates the use of a blood test for diagnosing celiac disease in adults, similar to the "no-biopsy" approach currently used in children. The detailed findings of the study were published in The Lancet Gastroenterology & Hepatology.

Related Links:
University of Salerno

Platinum Member
Flu SARS-CoV-2 Combo Test
OSOM® Flu SARS-CoV-2 Combo Test
Magnetic Bead Separation Modules
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV

Print article


Clinical Chemistry

view channel
Image: The new ADLM guidance will help healthcare professionals navigate respiratory virus testing in a post-COVID world (Photo courtesy of 123RF)

New ADLM Guidance Provides Expert Recommendations on Clinical Testing For Respiratory Viral Infections

Respiratory tract infections, predominantly caused by viral pathogens, are a common reason for healthcare visits. Accurate and swift diagnosis of these infections is essential for optimal patient management.... Read more


view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more


view channel
Image: For 46 years, Roche and Hitachi have collaborated to deliver innovative diagnostic solutions (Photo courtesy of Roche)

Roche and Hitachi High-Tech Extend 46-Year Partnership for Breakthroughs in Diagnostic Testing

Roche (Basel, Switzerland) and Hitachi High-Tech (Tokyo, Japan) have renewed their collaboration agreement, committing to a further 10 years of partnership. This extension brings together their long-standing... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.